ArticleCureus2022

The Role of Pre-treatment Inflammatory Biomarkers in the Prediction of an Early Response to Panitumumab in Metastatic Colorectal Cancer.

Angioletta Lasagna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.